newsfilter
← Latest News
Business Wire·

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions

AbCellera (NASDAQ:ABCL) today announced a collaboration with Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune